Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortWeekly dual-hormone injection with the largest weight loss of any approved drug.Weekly injection (or daily pill) for diabetes and weight loss.
Body systemDiabetes & WeightDiabetes & Weight
Drug classDual GIP/GLP-1 agonistsGLP-1 receptor agonists
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesType 2 diabetes, Obesity and overweight with health problems, Obstructive sleep apnoea with obesityType 2 diabetes, Obesity and overweight with health problems, Reducing heart attack and stroke risk, Kidney disease in type 2 diabetes, MASH (fatty liver inflammation)
How it worksCopies two gut hormones that control insulin, appetite and fat storage.Copies a gut hormone that boosts insulin after meals, slows the stomach and makes you feel full.
Starts working—Appetite falls within days; full effect over months
Half-lifeAbout 5 daysAbout 1 week
Typical adult doseStart 2.5 mg weekly, increasing by 2.5 mg every 4 weeks to 5–15 mg.Ozempic: 0.25 mg weekly, increased monthly to 0.5–2 mg. Wegovy: increased over 16 weeks to 2.4 mg weekly. Rybelsus: 3 mg rising to 7–14 mg daily, on an empty stomach with a sip of water.
FormsWeekly pen or vial injectionWeekly pen injection, Daily tablet
Common side effectsNausea, Diarrhoea, Vomiting, Constipation, Reduced appetiteNausea, Vomiting, Diarrhoea, Constipation, Reflux, Tiredness
Serious side effectsPancreatitis, Gallbladder disease, Dehydration and kidney injury, Aspiration under anaesthesiaPancreatitis, Gallstones, Dehydration and kidney injury from vomiting, Worsening diabetic eye disease with rapid sugar falls, Optic nerve damage (NAION, very rare), Aspiration during anaesthesia
Don't take if——
Alcohol——
PregnancyUsually avoidedStop at least 1 month before trying to conceive.Usually avoidedStop at least 2 months before trying to conceive.
Breastfeeding——
In use since20222017
Brand namesUnited States: Mounjaro, ZepboundUnited Kingdom: MounjaroIndia: MounjaroUnited States: Ozempic, Wegovy, RybelsusUnited Kingdom: Ozempic, Wegovy, RybelsusIndia: Ozempic, Wegovy, Rybelsus
Legal status——
ATC codeA10BX16A10BJ06

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker